New drug tested to stop dangerous bleeding in twin births
NCT ID NCT07401524
Summary
This study is testing if a drug called carbetocin works better than the standard treatment (oxytocin) to prevent heavy, dangerous bleeding after giving birth to twins. Researchers will compare the two treatments in 120 people delivering twins to see which one better reduces blood loss. The goal is to find a safer, more effective way to protect mothers' health during this higher-risk type of delivery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sheba Medical Center
Ramat Gan, 5262000, Israel
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.